Is there an age limit for Mounjaro, and does it affect your decision?

The hard rule: under 18, Mounjaro is not an option

The UK licence for tirzepatide as a weight-management medicine is unambiguous on this point. It covers adults, which in pharmaceutical law means people aged 18 and older. No UK prescriber can lawfully issue a Mounjaro prescription for weight management to someone under that age, and no registered pharmacy (including num's GPhC-registered pharmacy) can dispense it. If you want a fuller breakdown of the age limit that applies to Mounjaro prescriptions in the UK, that page walks through the licensing position and why it is fixed rather than discretionary. This is not a clinical grey area or a matter of individual prescriber discretion; it is a fixed boundary set by the medicine's authorisation.

The reason is straightforward. The clinical trials that established tirzepatide's safety and effectiveness (including SURMOUNT-1, which enrolled over 2,500 adults with obesity) were conducted in adults. There is simply no good evidence base for use in people under 18, and licensing bodies require that evidence before a medicine can be used in that population. If you are enquiring on behalf of a teenager, the right conversation is with a paediatrician or specialist children's weight-management service rather than any adult-medicine route. Our FAQs cover other common eligibility questions if that helps clarify what is and is not in scope.

No upper age ceiling, but more moving parts as you get older

There is no age at which Mounjaro automatically becomes unavailable. A healthy 65-year-old with a BMI of 33 and well-controlled type 2 hypertension can, in principle, be just as eligible as someone in their thirties with the same profile. The licence does not draw a line at 60, 65 or 70.

What does change with age is complexity. Kidney function tends to decline gradually over decades, and because tirzepatide slows gastric emptying and can cause nausea and vomiting, dehydration is a more pressing concern in older adults than in younger ones. Polypharmacy (the reality of taking several medicines at once) becomes more common too. A prescriber will look carefully at everything else a patient takes, because some medicines interact with tirzepatide's effects on absorption and gut motility. Muscle mass also matters: losing weight quickly without adequate protein and resistance exercise can accelerate the muscle loss that many older adults are already managing. None of these factors disqualifies someone from treatment, but they shift the clinical conversation. The clinical oversight at nume is built to catch exactly this kind of nuance, not to wave through every application identically.

The NHS itself notes on its tirzepatide guidance that the prescriber assesses individual suitability across a range of factors, age-related physiology is one of them. You can read the NHS patient information on tirzepatide for a plain-English summary of who should discuss extra cautions with their doctor.

What the eligibility criteria actually require, at any age

Mounjaro's licensed eligibility for weight management rests on two things: a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as high blood pressure, raised cholesterol, obstructive sleep apnoea or type 2 diabetes. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance. Age is not listed as an eligibility criterion in the positive sense, being older does not make you more or less likely to qualify on paper.

In practice, adults in their 50s, 60s and 70s are often well placed to benefit, because weight-related conditions accumulate with time and the clinical rationale for treatment becomes stronger, not weaker. If you are weighing up whether the private route makes sense before your GP can see you, the question of asking your GP for Mounjaro is worth understanding, NHS access is phased and criteria are strict. A private consultation cuts that wait entirely, subject to clinical suitability.

One thing worth timing well: if you are ordering through an online pharmacy and expecting same-day dispatch, check the 12pm weekday cut-off, there's no point placing a consultation on a Friday afternoon and expecting next-day delivery before a bank holiday weekend.

What this means for your next step

If you are 18 or over and meet the BMI threshold, age alone is unlikely to be the barrier. What matters is the whole clinical picture: other health conditions, current medications, and your individual goals. Treatments continue to evolve, alternatives to Mounjaro and newer molecules in late-stage trials may eventually expand the options available. For now, the decision on suitability sits with a prescriber, not an algorithm and not an age threshold.

On the cost side, it is worth knowing that a legitimate private prescription includes clinical assessment, the medicine itself, and aftercare, not just the pen. The cost of Mounjaro in the UK varies by dose and provider, and the headline figure often excludes several of those components. Understanding what is bundled in helps you compare honestly. When you are ready, check your eligibility with our prescribers, the consultation is free, and a real clinician reads your answers the same day.